1. |
Loiseau P, Beaussart M. The seizures of benign childhood epilepsy with Rolandic paroxysmal discharges. Epilepsia, 1973, 14(4): 381-389.
|
2. |
Guerrini R. Epilepsy in children. Lancet, 2006, 367(9509): 499-524.
|
3. |
Engel J, Jr. International League Against E. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia, 2001, 42(6): 796-803.
|
4. |
Panayiotopoulos CP, Michael M, Sanders S, et al. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain, 2008, 131(Pt 9): 2264-2286.
|
5. |
Dryzalowski P, Jozwiak S, Franckiewicz M, et al. Benign epilepsy with centrotemporal spikes - Current concepts of diagnosis and treatment. Neurol Neurochir Pol, 2018, 52(6): 677-689.
|
6. |
Vears DF, Tsai MH, Sadleir LG, et al. Clinical genetic studies in benign childhoodepilepsy with centrotemporal spikes. Epilepsia, 2012, 53(2): 319-324.
|
7. |
Bali B, Kull LL, Strug LJ, et al. Autosomal dominant inheritance of centrotemporal sharp waves in rolandic epilepsy families. Epilepsia, 2007, 48(12): 2266-2272.
|
8. |
Lee YJ, Hwang SK, Kwon S. The clinical spectrum of benign epilepsy with centro-temporal spikes: a challenge in categorization and predictability. J Epilepsy Res, 2017, 7(1): 1-6.
|
9. |
Xiong W, Zhou D. Progress in unraveling the genetic etiology of rolandic epilepsy. Seizure, 2017, 47: 99-104.
|
10. |
Addis L, Virdee JK, Vidler LR, et al. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue. Sci Rep, 2017, 7(1): 66.
|
11. |
Lesca G, Moller RS, Rudolf G, et al. Update on the genetics of the epilepsy-aphasia spectrum and role of GRIN2A mutations. Epileptic Disord, 2019, 21(S1): 41-47.
|
12. |
Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet, 2013, 45(9): 1067-1072.
|
13. |
Panjwani N, Wilson MD, Addis L, et al. A microRNA-328 binding site in PAX6 is associated with centrotemporal spikes of rolandic epilepsy. Ann Clin Transl Neurol, 2016, 3(7): 512-522.
|
14. |
Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign localization-related epilepsies in children: are they predictable? Epilepsia, 2000, 41(4): 380-390.
|
15. |
Cerminara C, Montanaro ML, Curatolo P, et al. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy. Neurology, 2004, 63(2): 373-375.
|
16. |
Parmeggiani L, Seri S, Bonanni P, et al. Electrophysiological characterization of spontaneous and carbamazepine-induced epileptic negative myoclonus in benign childhood epilepsy with centro-temporal spikes. Clin Neurophysiol, 2004, 115(1): 50-58.
|
17. |
Bouma PA, Bovenkerk AC, Westendorp RG, et al. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology, 1997, 48(2): 430-437.
|
18. |
Okubo Y, Matsuura M, Asai T, et al. Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia, 1994, 35(4): 832-841.
|
19. |
Liu MJ, Su XJ, Md XS, et al. Clinical features of benign epilepsy of childhood with centrotemporal spikes in chinese children. Medicine (Baltimore), 2017, 96(4): e5623.
|
20. |
Kim EH, Yum MS, Shim WH, et al. Structural abnormalities in benign childhood epilepsy with centrotemporal spikes (BCECTS). Seizure, 2015, 27: 40-46.
|
21. |
Thorn EL, Ostrowski LM, Chinappen DM, et al. Persistent abnormalities in Rolandic thalamocortical white matter circuits in childhood epilepsy with centrotemporal spikes. Epilepsia, 2020, 61(11): 2500-2508.
|
22. |
Overvliet GM, Aldenkamp AP, Klinkenberg S, et al. Correlation between language impairment and problems in motor development in children with rolandic epilepsy. Epilepsy Behav, 2011, 22(3): 527-531.
|
23. |
Shields WD, Snead OC, 3rd. Benign epilepsy with centrotemporal spikes. Epilepsia, 2009, 50 Suppl 8: 10-15.
|
24. |
Basnec A, Skarpa D, Barisic N, et al. The risk of second seizure in children with benign childhood epilepsy with centrotemporal spikes without treatment--a prospective study. Acta Med Croatica, 2005, 59(1): 59-62.
|
25. |
Arts WF, Geerts AT. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence. Eur J Paediatr Neurol, 2009, 13(2): 93-101.
|
26. |
Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013, 54(3): 551-563.
|
27. |
Asadi-Pooya AA, Forouzesh M, Eidi H, et al. Levetiracetam versus carbamazepine in treatment of rolandic epilepsy. Epilepsy Behav, 2019, 94: 1-8.
|
28. |
Liu WT, Yan XX, Cheng DZ, et al. Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life. Chin Med J (Engl), 2020, 133(14): 1649-1654.
|
29. |
Camfield CS, Camfield PR. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology, 2014, 82(13): 1162-1166.
|
30. |
Xie W, Ross EE, Kramer MA, et al. Timing matters: Impact of anticonvulsant drug treatment and spikes on seizure risk in benign epilepsy with centrotemporal spikes. Epilepsia Open, 2018, 3(3): 409-417.
|
31. |
Varesio C, Zanaboni MP, Salmin EC, et al. Childhood epilepsy with centrotemporal spikes: clinical and neuropsychological outcomes 5 years after remission. Diagnostics (Basel), 2020, 10(11).
|
32. |
Li Z, Zhang J, Wang F, et al. Surface-based morphometry study of the brain in benign childhood epilepsy with centrotemporal spikes. Ann Transl Med, 2020, 8(18): 1150.
|
33. |
Kramer U. Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review. J Child Neurol, 2008, 23(7): 785-790.
|